Anterpreet S Neki MD
Medical Director Marshall Cancer Center Cameron Park CA
Join to view full profile
3581 Palmer DrCameron Park, CA 95682
Phone+1 530-676-6600
Fax+1 530-748-0360
Dr. Neki is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1996 - 1999
District of Columbia General HospitalResidency, Internal Medicine, 1993 - 1996
Maulana Azad Medical CollegeClass of 1986
Certifications & Licensure
CA State Medical License 2023 - 2027
FL State Medical License 2011 - 2025
OH State Medical License 1997 - 2024
WV State Medical License 2011 - 2013
MI State Medical License 2011 - 2012
PA State Medical License 1997 - 1998
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
Publications & Presentations
PubMed
- 44 citationsPembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV...Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes, Anna Spreafico, Melanie Nordlinger
Journal of Clinical Oncology. 2024-09-01 - 7 citationsClinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma.C. Barney, Steve Walston, Pedro Zamora, E. Healy, Nicole Nolan
Oral Oncology. 2018-04-01 - 21 citationsPhase II Evaluation of Docetaxel-Modulated Capecitabine in Previously Treated Patients with Non–Small Cell Lung CancerTamila Kindwall-Keller, Gregory A. Otterson, Donn C. Young, Anterpreet Neki, Tamara Criswell
Clinical Cancer Research. 2005-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
